Drug research

Namodenoson 25mg

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as CF102

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Namodenoson Treatment of Advanced Pancreatic CancerNCT06387342	Can-Fite BioPharma	Phase 2	Recruiting	2026-07-15Estimated

Can-Fite BioPharmaRecruitingPrimary completion: 2026-07-15 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.